These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2962910

  • 1. Continuous, high-dose progestogen treatment of endometrial cancer.
    Szarvas Z, Zsolnai B, Gimes G, Hidvégi J.
    Gynecol Obstet Invest; 1987; 24(4):262-6. PubMed ID: 2962910
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
    Szarvas Z, Zsolnai B.
    Acta Chir Hung; 1984; 25(4):269-76. PubMed ID: 6240879
    [Abstract] [Full Text] [Related]

  • 4. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L.
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T, Karjalainen O.
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract] [Full Text] [Related]

  • 10. Cytochemical examinations of Ca, cytochrome oxidase and succinate dehydrogenase enzymes in endometrium carcinomatous tissue after high dose progestogen treatment.
    Szarvas Z, Balogh I, Patai K.
    Acta Morphol Hung; 1988 Oct; 36(3-4):177-83. PubMed ID: 2855777
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer.
    Lewis GC, Slack NH, Mortel R, Bross ID.
    Gynecol Oncol; 1974 Aug; 2(2-3):368-76. PubMed ID: 4616883
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of advanced endometrial cancer].
    Okada H, Yamamoto T.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma.
    Piver MS, Barlow JJ, Lurain JR, Blumenson LE.
    Cancer; 1980 Jan 15; 45(2):268-72. PubMed ID: 6985833
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
    Balogh F, Romics I.
    Z Urol Nephrol; 1987 Aug 15; 80(8):449-53. PubMed ID: 2961162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.